Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma

Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma

Oral cancer often presents with aggressive behavior and a high risk of recurrence and metastasis. For oral squamous cell carcinoma (OSCC), which is the most frequent histological subtype, therapy strategies include surgery, radiation therapy, chemotherapy, immune checkpoint inhibitors, and EGFR inhi...

Full description

Bibliographic Details
Main Authors:	Ramona Erber, Steffen Spoerl, Andreas Mamilos, Rosemarie Krupar, Arndt Hartmann, Matthias Ruebner, Juergen Taxis, Mareike Wittenberg, Torsten E. Reichert, Gerrit Spanier, Silvia Spoerl
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	International Journal of Molecular Sciences
Subjects:	Trop-2 TACSTD2 tumor associated calcium signal transducer 2 oral squamous cell carcinoma prognosis antibody-drug conjugates
Online Access:	https://www.mdpi.com/1422-0067/23/1/87

Similar Items

Trop-2 as a Therapeutic Target in Breast Cancer
by: Elizabeth Sakach, et al.
Published: (2022-11-01)

Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells
by: Gaku Nakato, et al.
Published: (2020-08-01)

TROP2 methylation and expression in tamoxifen-resistant breast cancer
by: Stephanie M. Zimmers, et al.
Published: (2018-07-01)

Trop2 Forms a Stable Dimer with Significant Structural Differences within the Membrane-Distal Region as Compared to EpCAM
by: Miha Pavšič
Published: (2021-09-01)

TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness
by: Jiří Švec, et al.
Published: (2022-08-01)

Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
by: Takashi Nishimura, et al.
Published: (2019-12-01)

The Significance of TROP2 Expression in Predicting Mutations in Papillary Thyroid Carcinoma
by: Joon Seog Kong, et al.
Published: (2018-01-01)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
by: Caili Xu, et al.
Published: (2023-11-01)

The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study
by: Farag AGA, et al.
Published: (2021-06-01)

Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
by: Yaozhong Hu, et al.
Published: (2022-07-01)

Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy
by: Jae Ho Jeong, et al.
Published: (2022-12-01)

Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks
by: Emanuela Guerra, et al.
Published: (2024-01-01)

Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
by: Hongyu Guan, et al.
Published: (2017-07-01)

The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance
by: Tomas Koltai, et al.
Published: (2023-12-01)

Targeting Trop2 in solid tumors: a look into structures and novel epitopes
by: Xinlin Liu, et al.
Published: (2023-12-01)

Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
by: Serkan Y Celik, et al.
Published: (2020-01-01)

Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
by: Yezhe Cheng, et al.
Published: (2022-12-01)

Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
by: Yezhe Cheng, et al.
Published: (2023-12-01)

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
by: Pasquale Lombardi, et al.
Published: (2023-03-01)

Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loop
by: Wenjuan Tang, et al.
Published: (2024-04-01)

Trop-2 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2022-05-01)

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
by: Raji Rhoda, et al.
Published: (2011-11-01)

Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins
by: Chuan-Jin Wu, et al.
Published: (2020-04-01)

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
by: Yeonjin Jeon, et al.
Published: (2022-09-01)

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
by: Mythili Shastry, et al.
Published: (2022-12-01)

Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus
by: Sascha Hoppe, et al.
Published: (2022-09-01)

TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma
by: Soji Toda, et al.
Published: (2022-01-01)

Trop2 Expression in Extramammary Paget’s Disease and Normal Skin
by: Takamichi Ito, et al.
Published: (2021-07-01)

Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation
by: Baoping Zhang, et al.
Published: (2020-08-01)

Head-to-Head Comparison of the Expression Differences of NECTIN-4, TROP-2, and HER2 in Urothelial Carcinoma and Its Histologic Variants
by: Yu Fan, et al.
Published: (2022-04-01)

The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody
by: Emanuela Guerra, et al.
Published: (2023-07-01)

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
by: Liqin Yao, et al.
Published: (2023-10-01)

L’UNITÉ LINGUISTIQUE TROP EN FRANÇAIS : GRAMMATICALISATION ET PRAGMATICALISATION / LINGUISTIC UNITY TROP IN FRENCH LANGUAGE: GRAMMATICALIZATION AND PRAGMATICALIZATION / UNITATEA LINGVISTICĂ TROP ÎN FRANCEZĂ: GRAMATICALIZARE ŞI PRAGMATICALIZARE
by: Amidou Sanogo
Published: (2016-11-01)

A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors
by: Giuliana Pavone, et al.
Published: (2021-12-01)

Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
by: Justine Jia Wen Seow, et al.
Published: (2021-04-01)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
by: Olga Katzendorn, et al.
Published: (2021-04-01)

TROP2 Expression in Sebaceous and Sweat Gland Carcinoma
by: Takamichi Ito, et al.
Published: (2022-01-01)

Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer
by: Emanuela Guerra, et al.
Published: (2021-09-01)

Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study
by: Steffen Spoerl, et al.
Published: (2022-12-01)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
by: Sara Bravaccini, et al.
Published: (2021-11-01)